Muplestim Uses, Dosage, Side Effects and more
Muplestim is under investigation in clinical trial NCT00002258 (A Phase I, Open Label Trial to Evaluate the Safety, Tolerance and Biological Effects of SDZ ILE-964 (Recombinant Human Interleukin-3, RhIL-3) in HIV Infected Patients With Cytopenia).
| Attribute | Details |
|---|---|
| Trade Name | Muplestim |
| Generic | Muplestim |
| Muplestim Other Names | Human interleukin-3 (nonglycosylated), Interleukin 3, Interleukin 3 (human), Interleukin-3, Interleukin-3 human (recombinant), Multipotential colony-stimulating factor, Muplestim |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
